TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health
Teladoc Health issued full-year 2026 revenue guidance of $2.47 billion to $2.59 billion in February 2026, then cut the low end by roughly $110 million months later -- and the stock fell nearly 30%. SueWallSt notifies investors of a pending investigation into potential securities law...
Covered in this story
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.